The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Open accessAbstract
Chronic hepatitis B virus (HBV) infection and dietary exposure to aflatoxin B 1 (AFB 1), two of the major risk factors in the multifactorial aetiology of hepatocellular carcinoma (HCC), co‐exist in those countries with the highest incidences of and the youngest patients with this tumour, raising the possibility of a synergistic carcinogenic interaction between the two agents. Experimental studies in HBV‐transgenic mice and woodchucks infected with woodchuck hepatitis virus were the first to show a synergistic hepatocarcinogenic effect between hepadnaviral infection and AFB 1 exposure. With the availability of urinary and serum biomarkers that more accurately reflect dietary exposure to AFB 1 than did the initially used food sampling and dietary questionnaires, cohort studies of patients with HCC in China and Taiwan have provided compelling evidence for a multiplicative or sub‐multiplicative interaction between HBV and AFB 1 in the genesis of human HCC. A number of possible mechanisms for the interaction have been suggested. Chronic HBV infection may induce the cytochrome P450s that metabolise inactive AFB 1 to the mutagenic AFB 1‐8,9‐epoxide. Hepatocyte necrosis and regeneration and the generation of oxygen and nitrogen reactive species resulting from chronic HBV infection increase the likelihood of the AFB 1‐induced p53 249 ser and other mutations and the subsequent clonal expansion of cells containing these mutations. Nuclear excision repair, which is normally responsible for removing AFB 1–DNA adducts, is inhibited by HBV×protein, favouring the persistence of existing mutations. This protein also increases the overall frequency of DNA mutations, including the p53 249 ser mutation, and may contribute to uncontrolled cell cycling when p53 is non‐functional.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
Zuckerman, A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.7.691-a · Cited by 8,728
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Bleyl, D. W. R. (1989) · Food / Nahrung · doi:10.1002/food.19890330516 · Cited by 2,305
Viral Hepatitis and Liver Disease
Vyas, G. N., Dienstag, J. L., & Hoofnagle, J. H. (1985) · Medical Entomology and Zoology · Cited by 1,860
Williams, J. H., Phillips, T. D., Jolly, P. E., Stiles, J. K., Jolly, C. M., & Aggarwal, D. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1106 · Cited by 1,781
Mutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Self-citationOhshima, H., & Bartsch, H. (1994) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(94)90245-3 · Cited by 1,055
Mechanisms of Aflatoxin Carcinogenesis
Eaton, D. L., & Gallagher, E. P. (1994) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.34.040194.001031 · Cited by 774
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
Ross, R. K., Yu, M. C., Henderson, B. E., Yuan, J.-M., Qian, G.-S., Tu, J.-T., Gao, Y.-T., Wogan, G. N., & Groopman, J. D. (1992) · The Lancet · doi:10.1016/0140-6736(92)91528-g · Cited by 725
Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice
Chisari, F. V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H. A., Sell, S., Pinkert, C. A., Brinster, R. L., & Palmiter, R. D. (1989) · Cell · doi:10.1016/0092-8674(89)90770-8 · Cited by 697
Qian, G.-S., Ross, R. K., Yu, M. C., Yuan, J., Gao, Y. T., Henderson, B. E., Wogan, G. N., & Groopman, J. D. (1994) · PubMed · Cited by 666
The toxicology of aflatoxins as a basis for public health decisions
Wild, C. P. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.471 · Cited by 475
Wang, J.-S., & Groopman, J. D. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00017-2 · Cited by 354
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in Southern Guangxi, China
Yeh, F.-S., Yu, M. C., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1990) · Health Policy · doi:10.1016/0168-8510(90)90389-u · Cited by 324
McGlynn, K. A., Rosvold, E. A., Lustbader, E. D., Hu, Y., Clapper, M. L., Zhou, T., Wild, C. P., Xia, X. L., Baffoe-Bonnie, A., & Ofori-Adjei, D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2384 · Cited by 275
Hepatocellular Carcinoma: From Gene to Public Health
Montesano, R., Hainaut, P., & Wild, C. P. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.24.1844 · Cited by 269
Aflatoxin exposure and risk of hepatocellular carcinoma in Taiwan
Wang, L.-Y., Hatch, M., Chen, C.-J., Levin, B., You, S.-L., Lu, S.-N., Wu, M.-H., Wu, W.-P., Wang, L.-W., Wang, Q., et al. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19960904)67:5<620::aid-ijc5>3.0.co;2-w · Cited by 259
Chen, C.-J., Liang, K.-Y., Chang, A.-S., Chang, Y.-C., Lu, S.-N., Liaw, Y.-F., Chang, W.-Y., Sheen, M.-C., & Lin, T.-M. (1991) · Hepatology · doi:10.1002/hep.1840130303 · Cited by 247
Ming, L., Thorgeirsson, S. S., Gail, M. H., Lu, P., Harris, C. C., Wang, N., Shao, Y., Wu, Z., Liu, G., Wang, X., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36366 · Cited by 233
Sun, Z., Lu, P., Gail, M. H., Pee, D., Zhang, Q., Ming, L., Wang, J., Wu, Y., Liu, G., Wu, Y., et al. (1999) · Hepatology · doi:10.1002/hep.510300204 · Cited by 220
Biological Control of Aflatoxin Contamination of Crops
Dorner, J. W. (2004) · Journal of Toxicology: Toxin Reviews · doi:10.1081/txr-200027877 · Cited by 220
Translational strategies for cancer prevention in liver
Kensler, T. W., Qian, G.-S., Chen, J.-G., & Groopman, J. D. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1076 · Cited by 213
Hepatitis B virus, aflatoxins, and hepatocellular carcinoma in southern Guangxi, China.
Yeh, F. S., Yuan, J., Mo, C.-C., Luo, S., Tong, M. J., & Henderson, B. E. (1989) · PubMed · Cited by 201
Aflatoxin exposure, hepatitis b virus infection and liver cancer in swaziland
Peers, F., Bosch, X., Kaldor, J., Linsell, A., & Pluijmen, M. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910390502 · Cited by 201
Elevated Aflatoxin Exposure and Increased Risk of Hepatocellular Carcinoma
Chen, C.-J., Wang, L.-Y., Lu, S.-N., Wu, M.-H., You, S.-L., Zhang, Y.-J., Wang, L.-W., & Santella, R. M. (1996) · Hepatology · doi:10.1002/hep.510240108 · Cited by 173
Lunn, R. M., Zhang, Y. J., Wang, L., Chen, C., Lee, P., Lee, C. S., Tsai, W. Y., & Santella, R. M. (1997) · PubMed · Cited by 170
Hepatitis B virus X protein inhibits nucleotide excision repair
Jia, L., Wang, X. W., & Harris, C. C. (1999) · International Journal of Cancer · Cited by 169
Oxy-radical induced mutagenesis of hotspot codons 248 and 249 of the human p53 gene.
Hussain, S. P., Aguilar, F., Amstad, P., & Cerutti, P. (1994) · PubMed · Cited by 148
Synergy between hepatitis B virus expression and chemical hepatocarcinogens in transgenic mice.
Sell, S., Hunt, J. M., Dunsford, H. A., & Chisari, F. V. (1991) · PubMed · Cited by 135
Wang, J., Qian, G., Zarba, A., He, X., Zhu, Y. R., Zhang, B.-C., Jacobson, L. P., Gange, S. J., Muñoz, Á., & Kensler, T. W. (1996) · PubMed · Cited by 135
Molecular dosimetry of aflatoxin-N7-guanine in human urine obtained in The Gambia, West Africa.
Groopman, J. D., Hall, A. J., Whittle, H., Hudson, G. J., Wogan, G. N., Montesano, R., & Wild, C. P. (1992) · PubMed · Cited by 121
Stern, M. C., Umbach, D. M., Yu, M. C., London, S. J., Zhang, Z., & Taylor, J. A. (2001) · PubMed · Cited by 112
Yu, M., Lien, J.-P., Chiu, Y. H., Santella, R. M., Liaw, Y., & Chen, C. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80178-x · Cited by 111
A case-control study of primary hepatocellular carcinoma in Taiwan
Lu, S., Lin, T., Chen, C., Chen, J. S., Liaw, Y., Chang, W., & Hsu, S. T. (1988) · Cancer · doi:10.1002/1097-0142(19881101)62:9<2051::aid-cncr2820620930>3.0.co;2-1 · Cited by 110
Chen, C., Yu, M., Liaw, Y., Wang, L. W., Chiamprasert, S., Matin, F., Hirvonen, A., Bell, D. A., & Santella, R. M. (1996) · PubMed Central · Cited by 109
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients
Jackson, P. E. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg101 · Cited by 105
Aflatoxin exposure, malaria and hepatitis B infection in rural Gambian children
Allen, S. J., Wild, C. P., Wheeler, J. G., Riley, E. M., Montesano, R., Bennett, S., Whittle, H., Hall, A. J., & Greenwood, B. M. (1992) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(92)90253-9 · Cited by 96
Aflatoxin detected in human breast milk by immunoassay
Wild, C. P., Pionneau, F., Montesano, R., Mutiro, C. F., & Chetsanga, C. J. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400308 · Cited by 92
Aflatoxin-albumin adducts: a basis for comparative carcinogenesis between animals and humans.
Wild, C. P., Hasegawa, R., Barraud, L., Chutimataewin, S., Chapot, B., Ito, N., & Montesano, R. (1996) · PubMed · Cited by 78
Omer, R. E., Kuijsten, A., Kadaru, A. M. Y., Kok, F. J., Idris, M. O., Khidir, I. M. E., & Veer, P. V. ’. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc4801_3 · Cited by 76
Madden, C. R., Finegold, M. J., & Slagle, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11770-11774.2002 · Cited by 73
Wild, C. P., Shrestha, S. M., Anwar, W. A., & Montesano, R. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90219-a · Cited by 53
Chen, S., Chen, C., Tsai, W., Ahsan, H., Liu, T.-Y., Lin, J., & Santella, R. M. (2000) · Nutrition and Cancer · doi:10.1207/s15327914nc382_6 · Cited by 46
Chen, S., Chen, C., Chou, S.-R., Hsieh, L., Wang, L., Tsai, W., Ahsan, H., & Santella, R. M. (2001) · PubMed · Cited by 42
Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan
Sun, C.-A., Wu, D.-M., Wang, L.-Y., Chen, C.-J., You, S.-L., & Santella, R. M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600584 · Cited by 30
Synergistic Effect of Hepatitis B Virus and Aflatoxin B1 in Hepatocarcinogenesis in Tree Shrews
Li, Y., Su, J. A. K. S., Ll, Q., et al. (1999) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v28n1p67 · Cited by 18
Cited by
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Hepatocellular carcinoma pathogenesis: from genes to environment
Farazi, P. A., & DePinho, R. A. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1934 · Cited by 1,979
Rushing, B. R., & Selim, M. I. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2018.11.047 · Cited by 989
Singal, A. G., Kanwal, F., & Llovet, J. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00825-3 · Cited by 951
Metadata
- Authors
- Kew, M. C.
- Venue
- Liver International
- Publisher
- Wiley
- Published
- 2003-11-27
- Volume
- 23
- Issue
- 6
- Pages
- 405-409
- ISSN
- 0106-9543 (ISSN-L)
- 1478-3223
- 1478-3231
- OpenAlex
- W1969363259
- Cited by
- 302
- References
- 49
- FWCI
- 5.38
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.